![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 20, 17385-17388, May 17, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
From the Departments of
Microbiology and
§ Pharmacology, The Center for Cell Signaling, The
University of Virginia, Charlottesville, Virginia 22908
Received for publication, October 26, 2001, and in revised form, March 27, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Ran-binding protein 3 (RanBP3) is an ~55-kDa
protein that functions as a cofactor for Crm1-mediated nuclear export.
RanBP3 stimulates export by enhancing the affinity of Crm1 for
Ran·GTP and cargo. However, important additional functions for
this cofactor may exist. We now report that RanBP3 associates with the
Ran-specific guanine nucleotide exchange factor, regulator of
chromosome condensation 1 (RCC1). This interaction was stimulated by
the addition of Ran; moreover, Ran·GDP, Ran·GTP, and Ran without
nucleotide could all stimulate complex formation between RanBP3 and
RCC1 even though binding of Ran·GDP to RanBP3 alone was undetectable.
RanBP3 could also promote binding of Crm1 to RCC1 in the presence of
Ran. Binding of RanBP3 to RCC1 increased the catalytic activity
of RCC1 toward Ran, and importantly, the ability of RanBP3 to
stimulate RCC1 was not affected by the presence of Crm1. These data
indicate that RanBP3 acts as a scaffold protein to promote the
efficient assembly of export complexes. By tethering Crm1 to
catalytically enhanced RCC1, RanBP3 may lower the entropic barrier for
the loading of Ran·GTP onto Crm1. We propose that this provides an
additional mechanism by which RanBP3 facilitates export.
Nuclear transport is an essential activity in all eukaryotic cells
(1, 2). All nuclear transport is believed to occur through the nuclear
pore complex (NPC),1 a large
glycoprotein complex that spans the double membrane of the nuclear
envelope (3). The NPC contains a central channel that permits transit
of cargoes between the nucleus and cytoplasm. The NPC is composed of
proteins called nucleoporins that possess binding sites for nuclear
transport receptors. These receptors (called importins, exportins,
transportins, and karyopherins) are able to bind simultaneously to
their cargo and nucleoporins to allow transport from one compartment to
the other.
The Ran GTPase controls most vectorial transport between the nucleus
and cytoplasm. Like other GTPases, Ran cycles between GDP- and
GTP-bound states. A single guanine nucleotide exchange factor (RCC1)
and GTPase-activating protein (RanGAP) catalyze the Ran GDP/GTP cycle
(4, 5). These proteins possess distinct subcellular localizations.
While RanGAP is localized to the cytoplasm and NPC (6), RCC1 is a
nuclear protein tethered to chromatin through histones H2A/H2B (6-8).
The disparate subcellular localizations of RanGAP and RCC1 predict a
steep gradient of Ran·GTP across the nuclear envelope, which is
crucial for most forms of nuclear transport.
A defining characteristic of The best characterized nuclear export receptor is Crm1 (also called
exportin-1 or Xpo1p in Saccharomyces cerevisiae). Crm1 is
able to associate with Ran·GTP and with cargo proteins harboring a
leucine-rich nuclear export signal (NES) (9-12). The
Crm1-cargo-Ran·GTP complex translocates across the NPC and is then
dissociated by hydrolysis of GTP on Ran, stimulated by RanGAP and other
required factors. Recently several cofactors have been identified that enhance nuclear export by Crm1. Nxt1 binds directly to Crm1 and Ran and
facilitates the delivery of the export complex to the cytoplasmic face
of the NPC (13). Another protein, eukaryotic initiation
factor-5A, may enhance the affinity of Crm1 for the NES of the
human immunodeficiency virus, type 1 protein Rev (14). Most
recently Ran-binding protein 3 (RanBP3) has been shown to enhance
nuclear export mediated by Crm1 (15, 16). RanBP3 binds directly to
Crm1, and the Crm1-RanBP3 complex has an enhanced affinity for both
Ran·GTP and cargo. The quaternary Crm1-RanBP3-Ran·GTP-NES complex
is able to interact with the NPC, mediating transport from the nucleus
to the cytoplasm. In the absence of Ran·GTP, RanBP3 prevents Crm1
from binding the NPC, thereby preventing futile export events.
Here we describe an additional independent mechanism by which RanBP3
may enhance nuclear export by Crm1. We demonstrate that RanBP3 can
interact with the Ran exchange factor RCC1 in a Ran-stimulated manner.
This interaction increases the catalytic activity of RCC1, accelerating
nucleotide exchange by ~10-fold. The activation of RCC1 by RanBP3
can be amplified by histones H2A/H2B, suggesting that
RanBP3 can stimulate RCC1 at the chromatin surface.
Furthermore, RanBP3 can promote binding of Crm1 to RCC1,
thereby tethering the export receptor to a region of
accelerated nucleotide exchange. We propose that RanBP3 acts
as a scaffold protein to promote the efficient assembly of
Crm1-dependent export complexes.
Cloning, Protein Expression, and Purification--
All
glutathione S-transferase (GST) fusion proteins were
prepared as described previously (17). Histones H2A and H2B were purchased from Roche Molecular Biochemicals. RCC1 and RCC1(D182A) were
cloned into a bait plasmid containing the DNA-binding domain from Gal4p
as an ~1200-bp BamHI/BamHI fragment. RCC1 was
also cloned as a BamHI/BamHI fragment into
pHis-Parallel2 and expressed in Escherichia coli (BL21) by
induction with 0.4 mM
isopropyl-1-thio- Yeast Two-hybrid Analysis--
Yeast dihybrid mating assays were
performed as described previously (15, 18). Briefly, bait plasmids
encoding RCC1 or RCC1(D182A) fused to the DNA-binding domain of
GAL4 were transformed into HF7c (MATa). Prey
plasmids encoding RanBP3 fused to the transactivation domain of VP16
were transformed into W303 (MAT Exchange Assays--
RCC1-catalyzed exchange assays were
performed as described previously (7, 19). Briefly, recombinant Ran was
loaded with [ Immunoblotting--
RCC1 was visualized using an anti-RCC1
antibody (1:200; N-19, Santa Cruz Biotechnology) and a horseradish
peroxidase-coupled rabbit anti-goat secondary antibody (1:20,000; The
Jackson Laboratories). RanBP3 was detected using anti-RanBP3 serum.
Crm1 was visualized using anti-Crm1 serum (a kind gift of Larry
Gerace) (15). Ran was detected using a mouse monoclonal anti-Ran
antibody (1:2,000; Transduction Laboratories) and a horseradish
peroxidase-coupled goat anti-mouse secondary antibody (1:20,000; The
Jackson Laboratories).
Binding Assays--
GST fusion proteins were immobilized on
glutathione (GSH)-Sepharose (Pharmacia) in phosphate-buffered saline.
After blocking the beads for 1 h at 4 °C in 5% BSA,
phosphate-buffered saline (w/v), binding reactions were accomplished in
binding buffer (20 mM HEPES (pH 7.4), 150 mM
NaCl, 2 mM MgCl2, 1 mg/ml BSA, 0.1% Tween 20 (v/v), 14 mM 2-mercaptoethanol, and 1 mM
GDP or GTP). Wild-type Ran was treated with immobilized GST-RanGAP for
90 min at 25 °C prior to use in binding assays to ensure that all
Ran protein was GDP-bound. For all binding reactions, the indicated form of Ran (10 µM), RanBP3 (10 µM), RCC1
(10 µM), or Crm1 (1 µM) was added. For all
assays using Crm1, the binding buffer was modified by increasing the
NaCl and 2-mercaptoethanol to 300 and 28 mM, respectively.
Beads were then washed in binding buffer without BSA. One-half of the
total bound proteins and RanBP3 has been shown to stimulate Crm1-dependent
nuclear export of NES-bearing cargoes in part by increasing the
affinity of Crm1 for its substrate (15, 16). However, it was unclear whether RanBP3 has additional distinct functions in nuclear transport. RanBP3 was originally cloned from a yeast two-hybrid screen using RCC1
as bait (20), which suggested that RanBP3 might play a role in
regulating nucleotide exchange on Ran. We first confirmed this
interaction using a yeast dihybrid mating assay. As shown in Fig.
1A, RCC1 was able to support
growth in a RanBP3-dependent manner. These data suggest
that RCC1 and RanBP3 are able to interact. However, RCC1(D182A), a
mutant that is unable to interact with Ran and catalyze nucleotide
exchange (21), did not support growth with RanBP3. Therefore, the
RCC1-RanBP3 interaction appears to be dependent upon the ability of
RCC1 to interact with Ran. These data are in agreement with those
reported previously for RanBP3 (20) and the S. cerevisiae
homologue Yrb2p (22).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-karyopherin transport receptors is
their direct interaction with Ran·GTP. The effect of Ran on the
interaction between the receptor and its cargo is dependent upon the
nature of the transport receptor. Ran·GTP dissociates cargo from
import receptors, while in contrast, Ran·GTP is required for an
export receptor to bind its cargo (1, 2). Upon transit of an export
complex into the cytoplasm, hydrolysis of Ran·GTP to Ran·GDP causes
release of the cargo from the export receptor. Thus, one essential
function of Ran is to regulate the interactions between receptors and
cargo in a compartment-specific manner.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-galactopyranoside at 18 °C for
16 h. After lysis of the bacteria, recombinant RCC1 was purified
on Ni2+-agarose (Qiagen). The His6 tag was
removed from RCC1 by incubation with the tobacco etch virus protease
(Invitrogen). Both the cleaved His6 tag and tobacco etch
virus protease were removed on Ni2+-agarose
(Qiagen). RanBP3, Ran, GST-R, GST-NF, and Crm1 were prepared as
described previously (15).
). The strains
were mated and plated on
Leu
Trp
His
medium.
-32P]GDP or [
-32P]GTP by
incubation in 25 mM MOPS (pH 7.1) and 1 mM
EDTA. After incubation on ice for 20 min, the reaction was quenched by
the addition of 10 mM MgCl2. All exchange
assays were performed at 30 °C for 3 min in exchange assay buffer
(25 mM MOPS (pH 7.1), 7.5 mM MgCl2,
0.6 mM NaH2PO4, 0.5 mg/ml BSA, and
1 mM GTP or GDP as indicated) containing ~0.6
nM RCC1. Reactions were stopped by binding to
nitrocellulose filters using a vacuum apparatus. After washing the
filters with ice-cold buffer (7.5 mM
NaH2PO4 (pH 6.8), 7.5 mM
Na2HPO4 (pH 6.8), 10 mM
MgCl2, and 1 mM ATP), the reactions were
analyzed by scintillation counting. Dissociation rate constants
(koff) were calculated assuming a single
exponential decay
(ln(Ct/C0) =
kofft, where
C0 is the radioactive counts at time 0 and
Ct is the counts at time t).

![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (28K):
[in a new window]
Fig. 1.
Ran stimulates binding of RCC1 to
RanBP3. A, S. cerevisiae W303
(MAT
) expressing the VP16 transactivation
domain alone or fused to Ran were mated with HF7c (MATa)
transformed with the Gal4p DBD alone or fused to RCC1 or RCC1(D182A).
Diploid yeast were replica plated onto
Leu
Trp
His
. B,
wild-type Ran·GDP or Ran(Q69L), a mutant Ran locked in the GTP-bound
state (all 10 µM), was incubated with GST or GST-RanBP3
bound to GSH beads. Bound and unbound proteins were subjected to
SDS-PAGE and immunoblotting. C, RCC1 was incubated ± Ran(Q69L) or wild-type Ran·GDP with GST or GST-BP3 bound to GSH
beads. Samples were analyzed as above. D, RCC1 ± Ran(Q69L) was incubated with GST, GST-BP3, GST-R (RanBP3 RBD), or
GST-NF (RanBP3 minus the RBD) bound to beads. Samples were analyzed as
above.
To determine whether Ran acts as a bridge to link RCC1 and RanBP3, we first analyzed the ability of RanBP3 to interact with Ran. RCC1 can interact with both Ran·GDP and Ran·GTP (4, 23); in contrast, RanBP3 has been reported to bind specifically, although with low affinity, only to Ran·GTP (20). To test these interactions, GST-tagged RanBP3 (GST-RanBP3) or GST alone was immobilized to GSH beads and incubated with Ran(Q69L) (a mutant Ran locked in the GTP-bound state) (5) or wild-type Ran·GDP. As shown in Fig. 1B, RanBP3 bound Ran(Q69L)·GTP; however, the affinity of RanBP3 for Ran·GDP was too low to be detectable. These data suggest that RanBP3 can only interact directly with Ran·GTP. We were also able to detect a direct interaction between RCC1 and RanBP3 (Fig. 1C); however, the interaction appeared very weak and only slightly above background. In contrast, the addition of Ran·GTP stimulated binding of RCC1 to RanBP3 by forming a trimeric complex between Ran, RCC1, and RanBP3 as reported previously (20). Interestingly Ran·GDP was also able to form a trimeric complex with RCC1 and RanBP3. Thus, although RanBP3 cannot interact with Ran·GDP directly (Fig. 1B), it is able to recognize Ran·GDP when bound to RCC1 (Fig. 1C). Ran depleted of bound nucleotide by treatment with EDTA and alkaline phosphatase could also form a trimeric complex with RCC1 and RanBP3 (data not shown). Therefore, in the presence of RCC1, RanBP3 is able to recognize Ran irrespective of its nucleotide state.
RanBP3 contains other domains in addition to the Ran-binding domain (RBD) (15). To determine which region of RanBP3 is responsible for the formation of the trimeric complex, we tested two fragments of the protein for binding to RCC1. The isolated RBD (GST-R) bound RCC1 in the presence of Ran·GTP, while a fragment that lacks the RBD (GST-NF) did not bind RCC1 (Fig. 1D). Therefore, the RanBP3 RBD is both necessary and sufficient to mediate the interaction between RanBP3, Ran, and RCC1.
Because RanBP3 can bind several of the putative reaction intermediates
of RCC1-catalyzed nucleotide exchange (23), we asked whether RanBP3
affects the enzymatic activity of RCC1. Ran, preloaded with
[
-32P]GDP or [
-32P]GTP, was incubated
with a fixed amount of RCC1 in the presence or absence of RanBP3. As
shown in Fig. 2, RanBP3 stimulated the catalytic activity of RCC1. RanBP3 increased the dissociation rate
constant (koff) for both
[
-32P]GDP and [
-32P]GTP, although the
effect for GDP appeared more robust. Furthermore, RanBP3 enhanced
exchange of [
-32P]GDP for unlabeled GDP (data not
shown). Because RanBP3 cannot bind directly to Ran·GDP (Fig.
1B), these data cannot be explained by product
sequestration. Furthermore, RanBP1, a protein that has been reported to
inhibit RCC1-catalyzed exchange (24), potently inhibited RCC1 within
the assay. Thus, although RanBP1 and RanBP3 have similar RBDs, these
data indicate that the two RBDs possess distinct biochemical activities
(see "Discussion").
|
Recently histones H2A/H2B have been shown to bind directly to RCC1 and stimulate its catalytic activity (7). Unlike the histone-RCC1 interaction, the interaction between RCC1 and RanBP3 is Ran-stimulated. This difference suggested that the surfaces on RCC1 that are recognized by RanBP3 and H2A/H2B may be distinct, and as such, the effects of these proteins on enhancing nucleotide exchange may be additive. To test this hypothesis directly, we titrated the effect of RanBP3 on RCC1-catalyzed nucleotide exchange in the presence and absence of a saturating amount of histones H2A/H2B (Fig. 2D). The histones stimulated RCC1 activity at all concentrations of RanBP3, demonstrating that RanBP3 and H2A/H2B have additive effects on RCC1.
RanBP3 has been shown to enhance Crm1-dependent nuclear
export (15, 16). RanBP3 binds directly to Crm1 and enhances the affinity of Crm1 for both Ran·GTP and cargo. Therefore, since RCC1
can bind RanBP3, it seemed possible that RCC1 might also interact with
Crm1 in a RanBP3-dependent manner. To test this hypothesis
directly, GST-RCC1 was immobilized to beads and incubated with Crm1 in
the presence or absence of Ran and RanBP3. In the absence of these
proteins, only background levels of Crm1 were bound to RCC1 (Fig.
3A). Ran bound RCC1; however,
it did not facilitate binding of Crm1. RanBP3 associated with RCC1 in a
Ran-stimulated manner (Fig. 1C). Only when Crm1, RanBP3, and
Ran were added could Crm1 associate with RCC1 (Fig. 3A).
Thus, Crm1 is able to bind RCC1 in a Ran-stimulated and
RanBP3-dependent manner, indicating that RCC1, Ran, RanBP3,
and Crm1 are able to form a quaternary complex. Interestingly, although
both Ran·GTP and Ran·GDP were able to stimulate binding of Crm1 to
RCC1 in the presence of RanBP3, Ran·GDP appeared more efficient at
recruiting Crm1 to RCC1 (Fig. 3B). These data suggest that
the Crm1-RanBP3 complex can more efficiently recognize Ran·GDP bound
to RCC1 than Ran·GTP. Importantly, when added to exchange assays,
Crm1 did not alter the ability of RanBP3 to stimulate RCC1 (Fig.
3C).
|
| |
DISCUSSION |
|---|
|
|
|---|
RanBP3 is a cofactor for Crm1-dependent nuclear export (15) and functions by increasing the affinity of Crm1 for both Ran·GTP and cargo. In the absence of Ran and cargo, RanBP3 also inhibits Crm1 from interacting with the NPC, thereby reducing futile cycles of transport. We now find that RanBP3 possesses an independent activity that is mediated through the interaction of the Crm1-RanBP3 complex with RCC1. Crm1-RanBP3 can form a Ran-dependent complex with RCC1. Although Ran is required to recruit RanBP3-Crm1 to RCC1, both Ran·GDP and Ran·GTP are able to facilitate this process. Furthermore, in the presence of the RanBP3-Crm1 complex, the enzymatic activity of RCC1 toward Ran is stimulated.
Based on these data, we propose that nuclear RanBP3 acts as a scaffold protein to facilitate efficient loading of Ran·GTP and cargo onto Crm1. RanBP3 functions by binding directly to Crm1. Although the binary Crm1-RanBP3 complex is able to bind both Ran·GTP and cargo (15), it has been predicted that ~80% of free nuclear Ran is GDP-bound (32) and cannot facilitate binding of Crm1-RanBP3 to cargo. In contrast, Ran·GDP can recruit Crm1-RanBP3 to RCC1. This recruitment stimulates the catalytic activity of RCC1, thereby promoting rapid loading of GTP. Conversion of Ran·GDP to Ran·GTP within the Crm1-RanBP3-Ran-RCC1 complex would promote export cargo binding to the Crm1. Release of the Crm1-RanBP3-Ran·GTP-export cargo complex from RCC1 may require additional cellular factors since in vitro binding of cargo is not sufficient to promote disassembly (data not shown). Alternatively no allosteric release mechanism may be necessary if the dissociation rate constant is sufficiently high.
Although neither Crm1, RanBP3, nor the Crm1-RanBP3 complex can detectably bind Ran·GDP (Fig. 1B, data not shown), both RanBP3 and Crm1-RanBP3 can be recruited to RCC1 by Ran·GDP (Figs. 1 and 3). These data demonstrate that RCC1 can remodel the structure of Ran·GDP such that it can be recognized by the Crm1-RanBP3 complex. Also, although RanBP3 possesses a RBD similar to that of RanBP1 (20), RanBP3 possesses a low affinity for Ran·GTP relative to RanBP1, and while RanBP3 stimulates nucleotide exchange by RCC1, RanBP1 is inhibitory (Fig. 1C) (24). However, it has been noted that critical residues for Ran binding within the RBD from RanBP1 are not present in RanBP3 (25). The residues on Ran involved in the GTP/GDP switch may provide the basis for the Ran·GTP-specific binding of RanBP1. Their absence in RanBP3 may account for the ability of RanBP3 to bind Ran·GDP in the presence of RCC1. We note that Nup2p, another protein with a RanBP1-like RBD, also does not inhibit RCC1 (26). Together these data demonstrate that, while the RBDs from RanBP1 and RanBP3 are similar, they harbor distinct biochemical activities. Furthermore, they demonstrate that the inhibitory activity of RanBP1 on RCC1 is not intrinsic to all proteins possessing a RanBP1-like RBD (see below).
Solution of the three-dimensional crystal structure of the RCC1-Ran
complex has provided insight into the enzymatic mechanism of RCC1 (27).
One interesting aspect of the structure is that the C terminus of Ran
appears to be deployed, suggesting that RCC1 can activate this
conformational switch in Ran. This hypothesis is supported by the fact
that RCC1 can enhance nucleotide exchange on a mutant Ran lacking its
C-terminal acidic tail (Ran
211DEDDDL) more rapidly than
on wild-type Ran (19). We suspected that RanBP3 might stimulate
exchange by facilitating the C-terminal switch. However, this mechanism
is unlikely because RanBP3 is capable of stimulating RCC1-mediated
exchange even on Ran
211DEDDDL (data not shown).
Although RCC1 is an essential protein for nuclear transport, it is also
essential for nuclear envelope assembly and mitotic spindle formation
(28-30). By binding to chromatin, it is believed that RCC1 creates a
high concentration of Ran·GTP at the chromatin surface. Interestingly
binding of RCC1 to histones H2A/H2B enhances the catalytic activity of
RCC1, and RanBP3 can further amplify the effect of histones. Thus,
RanBP3 may possess a role in cell cycle progression and nuclear
envelope biogenesis. The yeast homologue of RanBP3, Yrb2p, has been
implicated in cell cycle progression since disruption of
YRB2 results in prolongation of mitosis (31). Thus, a
potential role for RanBP3 in the mammalian cell cycle is worthy of
future research.
| |
ACKNOWLEDGEMENTS |
|---|
We thank L. Gerace for providing the anti-Crm1 serum, D. Görlich for the Ran(Q69L) cDNA, and T. Nishimoto for the RCC1 cDNA. We thank all members of the Macara laboratory for help during all phases of this study.
| |
FOOTNOTES |
|---|
* This work was supported by DHHS, National Institutes of Health Grant GM-50526.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Center for Cell Sig-naling, University of Virginia, HSC Box 800577, Charlottesville, VA 22908. Tel.: 434-982-0083; Fax: 434-924-1236; E-mail: amb7c@virginia.edu.
Published, JBC Papers in Press, April 3, 2002, DOI 10.1074/jbc.C100620200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: NPC, nuclear pore complex; RanBP3, Ran-binding protein 3; RBD, Ran-binding domain; RCC1, regulator of chromosome condensation 1; GAP, GTPase-activating protein; GST, glutathione S-transferase; NES, leucine-rich nuclear export signal; MOPS, 4-morpholinepropanesulfonic acid; BSA, bovine serum albumin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Görlich, D.,
and Kutay, U.
(1999)
Annu. Rev. Cell Dev. Biol.
15,
607-660[CrossRef][Medline]
[Order article via Infotrieve] |
| 2. |
Nakielny, S.,
and Dreyfuss, G.
(1999)
Cell
99,
677-690[CrossRef][Medline]
[Order article via Infotrieve] |
| 3. |
Stoffler, D.,
Fahrenkrog, B.,
and Aebi, U.
(1999)
Curr. Opin. Cell Biol.
11,
391-401[CrossRef][Medline]
[Order article via Infotrieve] |
| 4. |
Bischoff, F. R.,
and Ponstingl, H.
(1991)
Nature
354,
80-82[CrossRef][Medline]
[Order article via Infotrieve] |
| 5. |
Bischoff, F. R.,
Klebe, C.,
Kretschmer, J.,
Wittinghofer, A.,
and Ponstingl, H.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
2587-2591 |
| 6. |
Hopper, A. K.,
Traglia, H. M.,
and Dunst, R. W.
(1990)
J. Cell Biol.
111,
309-321 |
| 7. |
Nemergut, M. E.,
Mizzen, C. A.,
Stukenberg, T.,
Allis, C. D.,
and Macara, I. G.
(2001)
Science
292,
1540-1543 |
| 8. |
Ohtsubo, M.,
Okazaki, H.,
and Nishimoto, T.
(1989)
J. Cell Biol.
109,
1389-1397 |
| 9. |
Fornerod, M.,
Ohno, M.,
Yoshida, M.,
and Mattaj, I. W.
(1997)
Cell
90,
1051-1060[CrossRef][Medline]
[Order article via Infotrieve] |
| 10. |
Fukuda, M.,
Asano, S.,
Nakamura, T.,
Adachi, M.,
Yoshida, M.,
Yanagida, M.,
and Nishida, E.
(1997)
Nature
390,
308-311[CrossRef][Medline]
[Order article via Infotrieve] |
| 11. |
Ossareh-Nazari, B.,
Bachelerie, F.,
and Dargemont, C.
(1997)
Science
278,
141-144 |
| 12. |
Stade, K.,
Ford, C. S.,
Guthrie, C.,
and Weis, K.
(1997)
Cell
90,
1041-1050[CrossRef][Medline]
[Order article via Infotrieve] |
| 13. |
Black, B. E.,
Holaska, J. M.,
Levesque, L.,
Ossareh-Nazari, B.,
Gwizdek, C.,
Dargemont, C.,
and Paschal, B. M.
(2001)
J. Cell Biol.
152,
141-155 |
| 14. |
Hofmann, W.,
Reichart, B.,
Ewald, A.,
Muller, E.,
Schmitt, I.,
Stauber, R. H.,
Lottspeich, F.,
Jockusch, B. M.,
Scheer, U.,
Hauber, J.,
and Dabauvalle, M. C.
(2001)
J. Cell Biol.
152,
895-910 |
| 15. |
Lindsay, M. E.,
Holaska, J. M.,
Welch, K.,
Paschal, B. M.,
and Macara, I. G.
(2001)
J. Cell Biol.
153,
1391-1402 |
| 16. |
Englmeier, L.,
Fornerod, M.,
Bischoff, F. R.,
Petosa, C.,
Mattaj, I. W.,
and Kutay, U.
(2001)
EMBO Rep.
2,
926-932[CrossRef][Medline]
[Order article via Infotrieve] |
| 17. |
Nemergut, M. E.,
and Macara, I. G.
(2000)
J. Cell Biol.
149,
835-850 |
| 18. |
Plafker, S. M.,
and Macara, I. G.
(2000)
EMBO J.
19,
5502-5513[CrossRef][Medline]
[Order article via Infotrieve] |
| 19. |
Richards, S. A.,
Lounsbury, K. M.,
and Macara, I. G.
(1995)
J. Biol. Chem.
270,
14405-14411 |
| 20. |
Mueller, L.,
Cordes, V. C.,
Bischoff, F. R.,
and Ponstingl, H.
(1998)
FEBS Lett.
427,
330-336[CrossRef][Medline]
[Order article via Infotrieve] |
| 21. |
Azuma, Y.,
Seino, H.,
Seki, T.,
Uzawa, S.,
Klebe, C.,
Ohba, T.,
Wittinghofer, A.,
Hayashi, N.,
and Nishimoto, T.
(1996)
J. Biochem. (Tokyo)
120,
82-91 |
| 22. |
Taura, T.,
Schlenstedt, G.,
and Silver, P. A.
(1997)
J. Biol. Chem.
272,
31877-31884 |
| 23. |
Klebe, C.,
Prinz, H.,
Wittinghofer, A.,
and Goody, R. S.
(1995)
Biochemistry
34,
12543-12552[CrossRef][Medline]
[Order article via Infotrieve] |
| 24. |
Bischoff, F. R.,
Krebber, H.,
Smirnova, E.,
Dong, W.,
and Ponstingl, H.
(1995)
EMBO J.
14,
705-715[Medline]
[Order article via Infotrieve] |
| 25. |
Macara, I. G.
(1999)
Curr. Biol.
9,
R436-R439[CrossRef][Medline]
[Order article via Infotrieve] |
| 26. |
Denning, D.,
Mykytka, B.,
Allen, N. P.,
Huang, L., Al, B.,
and Rexach, M.
(2001)
J. Cell Biol.
154,
937-950 |
| 27. |
Renault, L.,
Kuhlmann, J.,
Henkel, A.,
and Wittinghofer, A.
(2001)
Cell
105,
245-255[CrossRef][Medline]
[Order article via Infotrieve] |
| 28. |
Dasso, M.
(2001)
Cell
104,
321-324[CrossRef][Medline]
[Order article via Infotrieve] |
| 29. |
Moore, J. D.
(2001)
Bioessays
23,
77-85[CrossRef][Medline]
[Order article via Infotrieve] |
| 30. |
Sazer, S.,
and Dasso, M.
(2000)
J. Cell Sci.
113,
1111-1118[Abstract] |
| 31. |
Noguchi, E.,
Saitoh, Y.,
Sazer, S.,
and Nishimoto, T.
(1999)
J. Biochem. (Tokyo)
125,
574-585 |
| 32. |
Smith, A. E.,
Slepchenko, B. M.,
Schaff, J. C.,
Loew, L. M.,
and Macara, I. G.
(2002)
Science
295,
488-491 |
This article has been cited by other articles:
![]() |
N. Sabri, P. Roth, N. Xylourgidis, F. Sadeghifar, J. Adler, and C. Samakovlis Distinct functions of the Drosophila Nup153 and Nup214 FG domains in nuclear protein transport J. Cell Biol., August 9, 2007; 178(4): 557 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Takayanagi, T. Ohashi, E. Yamashita, Y. Kurosaki, K. Tanaka, Y. Hakata, Y. Komoda, S. Ikeda, Y. Tsunetsugu-Yokota, Y. Tanaka, et al. Enhanced Replication of Human T-Cell Leukemia Virus Type 1 in T Cells from Transgenic Rats Expressing Human CRM1 That Is Regulated in a Natural Manner J. Virol., June 1, 2007; 81(11): 5908 - 5918. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Brown, C. Cloix, G. H. Jiang, E. Kaiserli, P. Herzyk, D. J. Kliebenstein, and G. I. Jenkins A UV-B-specific signaling component orchestrates plant UV protection PNAS, December 13, 2005; 102(50): 18225 - 18230. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Riddick and I. G. Macara A systems analysis of importin-{alpha}-{beta} mediated nuclear protein import J. Cell Biol., March 28, 2005; 168(7): 1027 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cushman, D. Stenoien, and M. S. Moore The Dynamic Association of RCC1 with Chromatin Is Modulated by Ran-dependent Nuclear Transport Mol. Biol. Cell, January 1, 2004; 15(1): 245 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hakata, M. Yamada, and H. Shida A Multifunctional Domain in Human CRM1 (Exportin 1) Mediates RanBP3 Binding and Multimerization of Human T-Cell Leukemia Virus Type 1 Rex Protein Mol. Cell. Biol., December 1, 2003; 23(23): 8751 - 8761. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Castillo, A. P. Vivancos, N. Jones, J. Ayte, and E. Hidalgo Schizosaccharomyces pombe Cells Lacking the Ran-binding Protein Hba1 Show a Multidrug Resistance Phenotype Due to Constitutive Nuclear Accumulation of Pap1 J. Biol. Chem., October 17, 2003; 278(42): 40565 - 40572. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |